Non-Classical HLA Target-Variant Watch for Immuno-Oncology

A subscription alert service for immuno-oncology drug developers that watches the fast-growing non-classical HLA allele catalog and flags any new allele that changes the protein sequence of their drug target or its ligand — e.g., HLA-E for NKG2A programs, MICA for NKG2D engagers.